Overview

A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency

Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
This study will evaluate a new and safe testing method for identifying medicines that can cause problems in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. We are looking for volunteers with G6PD deficiency who would be willing to donate blood samples.
Phase:
N/A
Details
Lead Sponsor:
Walter Reed Army Institute of Research (WRAIR)
Treatments:
Primaquine